Systematic review and meta-analysis shows heightened cardiovascular disease risk after severe SARS-CoV-2 infection, indicating a need for dedicated clinical monitoring for nine months.
Because of increased risk of CVD outcomes, management of persons who survived a severe SARS-CoV-2 infection is required, especially during the first nine months post-infection.
No takes yet. Share an insight, caveat, or question.
Starke et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: